SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-24-036808
Filing Date
2024-03-27
Accepted
2024-03-27 06:49:19
Documents
116
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K syrs-20231231.htm   iXBRL 10-K 2916270
2 EX-4.1 syrs-ex4_1.htm EX-4.1 26001
3 EX-10.26 syrs-ex10_26.htm EX-10.26 73810
4 EX-21.1 syrs-ex21_1.htm EX-21.1 8369
5 EX-23.1 syrs-ex23_1.htm EX-23.1 9573
6 EX-31.1 syrs-ex31_1.htm EX-31.1 14932
7 EX-31.2 syrs-ex31_2.htm EX-31.2 14689
8 EX-32.1 syrs-ex32_1.htm EX-32.1 8198
9 EX-32.2 syrs-ex32_2.htm EX-32.2 8205
10 EX-97.1 syrs-ex97_1.htm EX-97.1 24854
11 GRAPHIC img115384158_0.jpg GRAPHIC 989
12 GRAPHIC img115384158_1.jpg GRAPHIC 1068
13 GRAPHIC img115384158_2.jpg GRAPHIC 1100
14 GRAPHIC img115384158_3.jpg GRAPHIC 878
15 GRAPHIC img115384158_4.jpg GRAPHIC 1201
16 GRAPHIC img115384158_5.jpg GRAPHIC 885
17 GRAPHIC img115384158_6.jpg GRAPHIC 1246
18 GRAPHIC img115384158_7.jpg GRAPHIC 1163
19 GRAPHIC img115384158_8.jpg GRAPHIC 1140
20 GRAPHIC img115384158_9.jpg GRAPHIC 756
21 GRAPHIC img115384158_10.jpg GRAPHIC 1265
  Complete submission text file 0000950170-24-036808.txt   11871504

Data Files

Seq Description Document Type Size
22 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT syrs-20231231.xsd EX-101.SCH 1831367
120 EXTRACTED XBRL INSTANCE DOCUMENT syrs-20231231_htm.xml XML 1833018
Mailing Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140
Business Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140 617-744-1340
Syros Pharmaceuticals, Inc. (Filer) CIK: 0001556263 (see all company filings)

IRS No.: 453772460 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37813 | Film No.: 24785709
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)